Deep Pharma Intelligence
AI company for drug discovery, biomarker development and advanced R&D landscape
Deep Pharma Intelligence (DPI) is a leading UK-based strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, and Healthcare Tech industries.
Deep Pharma Intelligence is a joint venture created by Deep
Knowledge Analytics Pharma Division and BPT Analytics
(BiopharmaTrend) -- two highly specialized think tanks in the
area of biotech innovation profiling, business intelligence, and
biotech investment advisory. The company is dedicated to
producing powerful data mining and visualization systems,
interactive analytics tools, and industry reports offering deep
technical insights, business intelligence, and strategic
guidance in the high growth and significant opportunity areas
of the pharmaceutical industry, including artificial intelligence
(AI) in drug discovery, emerging therapeutic targets and drug
modalities, new therapies and technologies, promising
startups, and more.
Visit website: https://www.deep-pharma.tech/
Details last updated 27-Jun-2021
Deep Pharma Intelligence Creations
AI in Drug Discovery, Biomarker Development and Advanced R&D
05-Apr-2022
Online webinar about Artificial Intelligence in Drug Discovery organized by Deep Pharma Intelligence (FREE)
The Landscape of Cancer Vaccines and Research Platforms: The Cutting Edge
23-Nov-2021
Findings from a unique market study revealing R&D platforms for developing therapeutic cancer vaccines
People at Deep Pharma Intelligence
Topics mentioned on this page:
AI in Healthcare
